ロード中...
NEO100 enables brain delivery of blood‒brain barrier impermeable therapeutics
BACKGROUND: Intracarotid injection of mannitol has been applied for decades to support brain entry of therapeutics that otherwise do not effectively cross the blood–brain barrier (BBB). However, the elaborate and high-risk nature of this procedure has kept its use restricted to well-equipped medical...
保存先:
| 出版年: | Neuro Oncol |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7850137/ https://ncbi.nlm.nih.gov/pubmed/32877532 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa206 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|